Wikisage, the free encyclopedia of the second generation, is digital heritage
Topiramate: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m (Under_construction_icon.png) |
||
| Line 1: | Line 1: | ||
topiramate compared to phenobarbital result better effect on, both partial, generalized <ref>Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital</ref> | topiramate compared to phenobarbital result better effect on, both partial, generalized <ref>Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital</ref> | ||
Qudexy<sup>TM</sup> is an extended release form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref> | Qudexy<sup>TM</sup> is an extended release form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref> | ||
<gallery>File:Under_construction_icon.png</gallery> | |||
{{Wikidata|Q}} | {{Wikidata|Q}} | ||
==Links== | ==Links== | ||
Revision as of 03:21, 18 April 2016
topiramate compared to phenobarbital result better effect on, both partial, generalized [1] QudexyTM is an extended release form of topiramate and could be use in patient unable to swalow intact capsules [2]
Links
Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy
- ↑ Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital
- ↑ http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract